logo
Sign in

NANOVIS, LLC

COLUMBIA CITY, IN · Founded 2008 · Medtech · Private

Spinal interbody fusion device with hierarchical titanium dioxide nanotube surface and microporous titanium scaffold coating for enhanced osseointegration and bone ingrowth

Claim this profile

Follows are private to you and power your alerts

Updated · nanovis.ch

Sector
Medtech
Headquarters
COLUMBIA CITY, IN
Founded
2008
Latest Form D
$5.4M, Mar 2020
Total capital
$12.1M
Federal grants
$1M
3 awards · 2015
Rank in peer group#444 of 477
Private capital raised
$11.1M
10 Form D · last Mar 2020
79 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
17 pending · first 2020
Rank in peer group#49 of 477

Capital timeline

200920112013201520172019FEDERAL ↑EQUITY ↓Cumulative $16.7M$678K$213K$150K2nd Form D$874K10th Form D$5.4M
200920112013201520172019FEDERAL ↑EQUITY ↓Cumulative $16.7M$678K$213K

Latest events

  • Private capital raisedForm D · SEC · 10th filing$5.4M
  • Private capital raisedForm D · SEC · 9th filing$770K
  • Offering registeredForm D · SEC · 8th filing$3.8M
  • Private capital raisedForm D · SEC · 7th filing$1.1M
  • Private capital raisedForm D · SEC · 6th filing$750K
  • Federal grantHealth and Human S · Phase I · Spinal Pseudoarthrosis Mitigation Using Nano Devices$150K
  • Federal grantHealth and Human S · Phase I · Durable Biomechanical Stabilization of Spinal Fusion Segments Despite Pseudoarthrosis Using Spinal Implants with Nano and Micron Porous Hierarchical Structures in a Novel Non-Union Model$213K
  • Private capital raisedForm D · SEC · 5th filing$2.5M
  • Private capital raisedForm D · SEC · 4th filing$372K
  • Private capital raisedForm D · SEC · 3rd filing$70K
  • Offering registeredForm D · SEC · 2nd filing$874K
  • Private capital raisedForm D · SEC · 1st filing$100K
Show 1 earlier federal award
  • Federal grantHealth and Human S · Phase II · Development and Commercialization of Nanostructured Resorbable Urogenital Grafts$678K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#49 · top 10%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Matthew HedrickResearcherExecutive OfficerLinked by 3 patents
  • Brian EmerickDirector, PromoterNamed in SEC Form D filings
  • Brian MoreExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • CHRISTOPHER EDWARD LAMOTHEDirectorNamed in SEC Form D filings
  • Steve GerrishDirectorNamed in SEC Form D filings
  • v Edward GroggDirectorNamed in SEC Form D filings
Show all 7 people
  • V. Edward GroggDirectorNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 23
Show all 23 patent records
  • Inactivating Bacteria With Electric Pulses And AntibioticsJun 19, 2025 · Application 19045055Pending
  • Pulsed Nano Surfacing MethodsJun 19, 2025 · Application 19071998Pending
  • Inactivating Bacteria With Electric Pulses And AntibioticsMar 18, 2025 · US 12,251,439Granted
  • Anti-microbial Device And Method For Its ManufactureJan 2, 2025 · Application 18829556Pending
  • Devices And Methods For Treating Infected TissueJun 20, 2024 · Application 18588877Pending
  • Anti-microbial Device And Method For Its ManufactureFeb 15, 2024 · Application 18481827Pending
  • Kits, Systems, And Methods For Reducing Surgical Site InfectionsDec 28, 2023 · Application 18334155Pending
  • Inactivating Bacteria With Electric Pulses And AntibioticsDec 19, 2023 · US 11,844,835Granted
  • Anti-microbial Device And Method For Its ManufactureOct 10, 2023 · US 11,779,684Granted
  • Anti-microbial Device And Method For Its ManufactureSep 28, 2021 · US 11,129,924Granted
  • Inactivating Bacteria With Electric Pulses And AntibioticsSep 21, 2021 · US 11,123,428Granted
  • Anti-microbial Device And Method For Its ManufactureMar 3, 2020 · US 10,576,186Granted
  • Anti-microbial Device And Method For Its ManufactureApplication PCTUS2015022743Pending
  • Electrodeposition Using Ultrashort Duration PulsesApplication PCTUS2024048303Pending
  • Nano Calcium Phosphate SurfacesApplication 63670452Pending
  • Electrodeposition Using High Power Ultrashort Duration PulsesApplication 63585386Pending
  • Pulsed Nano Surfacing MethodsApplication PCTUS2023073831Pending
  • Pulsed Nano Surfacing MethodsApplication 63375087Pending
  • Devices And Methods For Treating Infected TissueApplication PCTUS2022075628Pending
  • Kits, Systems, And Methods For Reducing Surgical Site InfectionsApplication PCTUS2021063066Pending
  • Devices And Methods To Treat Localized InfectionsApplication 63238626Pending
  • Kits, Systems, And Methods For Reducing Surgical Site InfectionsApplication 63125135Pending
  • Nano Calcium Phosphate SurfacesApplication PCTUS2025037381Pending

Related companies, and why

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .